Michael Helmrath

Michael A. Helmrath, MD


  • Director, Center for Stem Cell & Organoid Medicine (CuSTOM)
  • Director, Surgical Research
  • Director, Center for Bariatric Research and Innovation
  • Pediatric Surgeon
  • Professor, UC Department of Surgery

About

Biography

As a pediatric surgeon-scientist, I'm dedicated to helping patients with intestinal diseases and obesity. I always wanted to be a physician — caring for children and conducting research focused on strategies to improve the outcomes of those with intestinal failure.

My clinical interests are bariatric surgery and surgery to correct intestinal failure. My clinical work allows me to translate gastrointestinal conditions into the laboratory, where we are working to develop highly innovative approaches for treating intestinal diseases.

In my research lab, I've established a multidisciplinary team dedicated to translational, clinical, and basic science research focused on intestinal diseases. We are characterizing intestinal stem cells during adaptation and are working to develop intestinal regenerative strategies.

I believe that understanding the biology of intestinal stem cells is key to unraveling the mechanisms involved during the disease process. In my lab, we've developed in vitro culture techniques to maintain and expand individual human intestinal stem cells derived from human tissue samples, pluripotent stem cells, and surgical animal models.

I serve as the Director of Surgical Research, Director of the Center for Bariatric Research and Innovation, and Director of the Center for Stem Cell & Organoid Medicine (CuSTOM). I am board certified in General Surgery and Pediatric Surgery.

BA: Miami University, Oxford, OH, 1987.

MD: University of Cincinnati College of Medicine, Cincinnati, OH, 1993.

MS: University of Cincinnati College of Medicine, Cincinnati, OH, 1989.

Certification: Board-certified General Surgery; board-certified, Pediatric Surgery.

Interests

Surgery - general and thoracic; intestinal disorders; surgical weight loss

Interests

Intestinal diseases research

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

A shift in PKM2 oligomeric state instructs adipocyte inflammatory potential. Damen, MS; Alarcon, PC; Chan, CC; Stankiewicz, TE; Chung, H; Sawada, K; Ulanowicz, CJ; Eom, J; Oates, JR; Wayland, JL; Helmrath, MA; Sanchez-Gurmaches, J; Moreno-Fernandez, ME; Divanovic, S. JCI insight. 2025; 10:e185914.

Thermal Annealing Enhances Piezoelectricity and Regenerative Potential of PVDF-TrFE Nanofiber Scaffolds. Krutko, M; Poling, HM; Sheth, M; Kongsomros, S; Bryan, AE; Sharma, M; Singh, A; Reza, HA; Wikenheiser-Brokamp, KA; Takebe, T; Helmrath, MA; Harris, GM; Esfandiari, L. Advanced Materials Technologies. 2025; 10.

Use of Ovarian Tumor Markers in Prediction of Malignancy Risk in Pediatric and Adolescent Patients. Lin, AM; Bergus, KC; Bricker, J; Fallat, M; Hertweck, SP; Hewitt, G; Lutz, C; Aldrink, JH; Bence, C; Breech, L; St Peter, SD; Asti, L; Deans, K; Minneci, PC. Journal of Surgical Research. 2025; 315:839-846.

Exploring Organ-Specific Extracellular Vesicles in Metabolic Improvements Following Bariatric Surgery in Youth With Obesity. Kim, A; Okura, T; Choi, K; Gill, R; Borra, VJ; Murakami, K; Poulos, A; Zhang, X; Jenkins, T; Shah, AS; Helmrath, M; Nakamura, T. Obesity. 2025; 33:2181-2194.

Autologous Organoid-T Cell Co-Culture Platform for Modeling of Immune-Mediated Drug-Induced Liver Injury. Soussi, FE A; Brusilovsky, M; Buck, E; Bacon, WC; Dadgar, S; Fullerton, A; Durban, VM; Barrile, R; Helmrath, MA; Takebe, T; Roth, A; Kasendra, M. Advanced Science. 2025; 12:e08584.

Co-development of mesoderm and endoderm enables organotypic vascularization in lung and gut organoids. Miao, Y; Pek, NM; Tan, C; Jiang, C; Yu, Z; Iwasawa, K; Shi, M; Kechele, DO; Sundaram, N; Pastrana-Gomez, V; Zorn, AM; Chen, YW; Guo, M; Gu, M. Cell. 2025; 188:4295-4313.e27.

Parenteral nutrition weaning in pediatric intestinal failure patients enrolled in remote patient monitoring: A descriptive study. Oliveira, SB; Thomas, JD; Cole, C; Helmrath, M; Kocoshis, S; Wales, PW. Journal of Parenteral and Enteral Nutrition. 2025; 49:768-772.

Integrating collecting systems in human kidney organoids through fusion of distal nephron to ureteric bud. Shi, M; Crouse, B; Sundaram, N; Pode Shakked, N; Thorner, K; King, NM; Dutta, P; Ester, L; Zhang, W; Govindarajah, V; Mayhew, CN; Helmrath, MA; Bonventre, JV; McCracken, KW. Cell Stem Cell. 2025; 32:1055-1070.e8.

Functional mobility and pain are improved for 6 years after adolescent bariatric surgery. Thivalapill, N; Jenkins, TM; Inge, TH; Xie, C; Courcoulas, AP; Harmon, CM; Helmrath, MA; Sisley, S; Michalsky, MP; Ryder, JR. Obesity. 2025; 33:1126-1135.

Coordinated differentiation of human intestinal organoids with functional enteric neurons and vasculature. Childs, CJ; Poling, HM; Chen, K; Tsai, YH; Wu, A; Vallie, A; Eiken, MK; Huang, S; Sweet, CW; Schreiner, R; Helmrath, MA; Walton, KD; Rafii, S; Spence, JR. Cell Stem Cell. 2025; 32:640-651.e9.

From the Blog

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...
Loading ...